RHRobert B. Hines

Robert B. Hines

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert B. Hines has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Alina Barrett

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications
  • Dominique Broccoli

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications
  • Kimberly K. Engelman

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications
  • Lisette Jacobson

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications
  • Michelle Redmond

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications
  • Philip Twumasi-Ankrah

    From the University of Kansas School of Medicine-Wichita, Wichita, Kansas; Memorial University Medical Center, Savannah, Georgia; University of Kansas Medical Center, Kansas City, Kansas; and Georgia Southern University, Statesboro, Georgia

    2 shared publications

Latest Publications

  • Predictors of Guideline Treatment Nonadherence and the Impact on Survival in Patients With Colorectal Cancer

    by Robert B. Hines, Alina Barrett, Philip Twumasi-Ankrah, Dominique Broccoli, Kimberly K. Engelman, Joaquina Baranda, Elizabeth A. Ablah, Lisette Jacobson, Michelle Redmond, Wei Tu, et al.

    Background: This study investigated the effect of comorbidity, age, health insurance payer status, and race on the risk of patient nonadherence to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers. In addition, the prognostic impact of NCCN treatment nonadherence on overall survival was assessed. Patients and Methods: Patients with CRC who received primary treatment at Memorial University Medical Center from 2003 to 2010 were eligible for this study. Modified Poisson regression was used to obtain risk ratios for the outcome of nonadherence with NCCN Guidelines. Hazard ratios (HRs) for the relative risk of death from all causes were obtained through Cox regression. Results: Guideline-adherent treatment was received by 82.7% of patients. Moderate/severe comorbidity, being uninsured, having rectal cancer, older age, and increasing tumor stage were associated with increased risks of receiving nonadherent treatment. Treatment nonadherence was associated with 3.6 times the risk of death (HR, 3.55; 95% CI, 2.16–5.85) in the first year after diagnosis and an 80% increased risk of death (HR, 1.80; 95% CI, 1.14–2.83) in years 2 to 5. The detrimental effect of nonadherence declined with increasing comorbidity and varied according to age. Conclusions: Although medically justifiable reasons exist for deviating from NCCN Guidelines when treating patients with colorectal cancer (CRC), those who received nonadherent treatment had much higher risks of death, especially in the first year after diagnosis. This study’s results highlight the importance of cancer health services research to drive quality improvement efforts in cancer care for patients with CRC. Background: This study investigated the effect of comorbidity, age, health insurance payer status, and race on the risk of patient nonadherence to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers. In addition, the prognostic impact of NCCN treatment nonadherence on overall survival was assessed. Patients and Methods: Patients with CRC who received primary treatment at Memorial University Medical Center from 2003 to 2010 were eligible for this study. Modified Poisson regression was used to obtain risk ratios for the outcome of nonadherence with NCCN Guidelines. Hazard ratios (HRs) for the relative risk of death from all causes were obtained through Cox regression. Results: Guideline-adherent treatment was received by 82.7% of patients. Moderate/severe comorbidity, being uninsured, having rectal cancer, older age, and increasing tumor stage were associated with increased risks of receiving nonadherent treatment. Treatment nonadherence was associated with 3.6 times the risk of death (HR, 3.55; 95% CI, 2.16–5.85) in the first year after diagnosis and an 80% increased risk of death (HR, 1.80; 95% CI, 1.14–2.83) in years 2 to 5. The detrimental effect of nonadherence declined with increasing comorbidity and varied according to age. Conclusions: Although medically justifiable reasons exist for deviating from NCCN Guidelines when treating patients with colorectal cancer (CRC), those who received nonadherent treatment had much higher risks of death, especially in the first year after diagnosis. This study’s results highlight the importance of cancer health services research to drive quality improvement efforts in cancer care for patients with CRC.


  • Predictors of guideline treatment nonadherence and the impact on survival in patients with colorectal cancer.

    by Robert B. Hines, Alina Barrett, Philip Twumasi-Ankrah, Dominique Broccoli, Kimberly K. Engelman, Joaquina Celebre Baranda, Elizabeth Ablah, Lisette Jacobson, Michelle Redmond, Wei Tu, et al.

    254 Background: We investigated the effect of comorbidity, age, health insurance payer status, and race on the risk of nonadherence with National Comprehensive Cancer Network (NCCN) treatment guidelines for colorectal cancer (CRC) patients. In addition, the prognostic impact of NCCN treatment nonadherence on survival was assessed. Methods: Colon and rectal cancer patients who received primary treatment at Memorial University Medical Center in Savannah, GA from 2003 to 2010 were eligible for this study (final N = 679). Modified Poisson regression was used to obtain risk ratios for the outcome of nonadherence with NCCN treatment guidelines. Hazard ratios (HRs) for the relative risk of CRC-related death were obtained by Cox regression. Results: Guideline-adherent treatment was received by 82.5% of patients. Moderate/severe comorbidity, being uninsured, having rectal cancer, older age, and increasing tumor stage were associated with increased risks of receiving nonadherent treatment. Treatment nonadherence was associated with 4.5 times the risk of CRC-related death (HR, 4.53; 95% CI, 2.56-8.00) in the first year following diagnosis and 2.0 times the risk of death (HR, 1.97; 95% CI, 1.20-3.25) in years 2 to 5. The detrimental effect of nonadherence was demonstrated across all levels of comorbidity and age. Conclusions: Although there are medically justifiable reasons to deviate from NCCN treatment guidelines in CRC patients, patients who received nonadherent treatment had much higher risks of CRC-related death, especially in the first year following diagnosis. This study’s results highlight the importance of cancer health services research to drive quality improvement efforts in cancer care for CRC patients. [Table: see text]


  • Geographic Residency Status and Census Tract Socioeconomic Status as Determinants of Colorectal Cancer Outcomes

    by Robert Hines, Talar Markossian, Asal Johnson, Frank Dong, Rana Bayakly

    Objectives. We examined the impact of geographic residency status and census tract (CT)-level socioeconomic status (SES) on colorectal cancer (CRC) outcomes. Methods. This was a retrospective cohort study of patients diagnosed with CRC in Georgia for the years 2000 through 2007. Study outcomes were late-stage disease at diagnosis, receipt of treatment, and survival. Results. For colon cancer, residents of lower-middle-SES and low-SES census tracts had decreased odds of receiving surgery. Rural, lower-middle-SES, and low-SES residents had decreased odds of receiving chemotherapy. For patients with rectal cancer, suburban residents had increased odds of receiving radiotherapy, but low SES resulted in decreased odds of surgery. For survival, rural residents experienced a partially adjusted 14% (hazard ratio [HR] = 1.14; 95% confidence interval [CI] = 1.07, 1.22) increased risk of death following diagnosis of CRC that was somewhat explained by treatment differences and completely explained by CT-level SES. Lower-middle- and low-SES participants had an adjusted increased risk of death following diagnosis for CRC (lower-middle: HR = 1.16; 95% CI = 1.10, 1.22; low: HR = 1.24; 95% CI = 1.16, 1.32). Conclusions. Future efforts should focus on developing interventions and policies that target rural residents and lower SES areas to eliminate disparities in CRC-related outcomes.